Neumora Therapeutics (NMRA) Non-Current Assets (2022 - 2026)

Neumora Therapeutics' Non-Current Assets history runs 5 years deep, the most recent figure standing at $443000.0 for Q1 2026.

• In Q1 2026, Non-Current Assets fell 76.46% year-over-year to $443000.0; the TTM figure through Mar 2026 stood at $2.6 million (down 82.39% YoY), while the FY2025 annual figure was $510000.0, down 82.52% from the prior year.
• Non-Current Assets was $443000.0 for Q1 2026 at Neumora Therapeutics, down from $510000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $38.3 million in Q4 2022 to a low of $443000.0 in Q1 2026.
• Historically, Non-Current Assets has averaged $8.3 million across 5 years, with a median of $3.4 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Non-Current Assets plunged 53.2% in 2023, then tumbled 85.12% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $38.3 million in 2022, then slumped by 53.2% to $17.9 million in 2023, then plunged by 83.72% to $2.9 million in 2024, then sank by 82.52% to $510000.0 in 2025, then dropped by 13.14% to $443000.0 in 2026.
• The last three Non-Current Assets figures came in at $443000.0 (Q1 2026), $510000.0 (Q4 2025), and $751000.0 (Q3 2025), per Business Quant data.